Home/Filings/4/0001214659-25-000554
4//SEC Filing

Laponis Adam 4

Accession 0001214659-25-000554

CIK 0001581280other

Filed

Jan 13, 7:00 PM ET

Accepted

Jan 14, 4:05 PM ET

Size

5.2 KB

Accession

0001214659-25-000554

Insider Transaction Report

Form 4
Period: 2025-01-10
Laponis Adam
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2025-01-10$43.26/sh5,886$254,646110,096 total
Footnotes (1)
  • [F1]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Issuer

Twist Bioscience Corp

CIK 0001581280

Entity typeother

Related Parties

1
  • filerCIK 0001827198

Filing Metadata

Form type
4
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 4:05 PM ET
Size
5.2 KB